NEW YORK, NY: PRWeek and MM&M have revealed the 2017 Health Influencer 50, a list honoring professionals across the health spectrum for their passion, determination, and innovative thinking that has helped guide the industry through two turbulent and exciting decades.
As part of the 2017 reveal, the two brands pooled their resources to bring you the content on a sleek, unified website, which houses the Health Influencer 50 list on one platform, as well as special features, infographics, thought leadership pieces, and partner content. The site can be accessed at: www.HealthInfluencer50.com.
PRWeek and MM&M examined how health agencies are restructuring to best serve clients in this new environment, why pharma companies are increasingly embracing earned media to lead their communications, and what’s next for opioid marketing given the current addiction crisis in communities across the U.S.
"Health is a crucially important part of the communications and marketing landscape and comprises significant percentages of agency billings," says Steve Barrett, VP, editorial director, PRWeek/MM&M. "The U.S. healthcare system continues to face a period of incredible flux, on top of which innovation, new technologies, and young consumers will create a very different landscape. The members of our second Health Influencer 50 list lead the way in shaping that landscape."
The influence of these honorees is felt across the industry — from devising far-reaching, patient-centric strategies to leading the charge on healthcare’s data revolution. These 50 influencers often venture into uncharted territory to create a vision for the future.
"Nearly all facets of the healthcare industry are being disrupted, or are ripe for disruption," says Marc Iskowitz, editor-in-chief of MM&M. "As new entrants and entrepreneurs take a fresh look at the biopharma lifecycle, our Health Influencer 50 have the qualities essential to moving the industry forward: prescience (to anticipate transformative trends), perspective (to recognize when the time is right to embrace them), and persuasiveness (to get others to follow suit). As such, they’re redrawing the healthcare map for biotech, pharma, and medtech."
